In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Verastem Inc. (NASDAQ:VSTM) reported that 1globe Capital Llc. has picked up 342,353 of common stock as of 2017-06-13.
The acquisition brings the aggregate amount owned by 1globe Capital Llc. to a total of 342,353 representing 0.93% stake in the company.
For those not familiar with the company, Verastem, Inc. is a biopharmaceutical company. The Company is focused on discovering and developing drugs to improve outcomes for patients with cancer. The Company operates in the segment of developing drugs for the treatment of cancer. The Company’s advanced product candidates are VS 6063, VS 4718 and VS 5584. The Company’s programs target the Focal Adhesion Kinase (FAK) and the PI3K/mTOR signaling pathways. FAK is a non-receptor tyrosine kinase encoded by the PTK-2 gene that is involved in cellular adhesion and, in cancer, metastatic capability. The Company’s VS-6063 (defactinib) and VS 4718 are orally available small molecule compounds designed to inhibit FAK signaling. The Company’s VS-5584 is an orally available small molecule that inhibits both mTORC1/2 and PI3K signaling. The Company is engaged in running clinical trials in cancers where there are limited treatment options, including lung, ovarian, lymphoma, pancreatic and other advanced cancers.
A glance at Verastem Inc. (NASDAQ:VSTM)’s key stats reveals a current market capitalization of 77.31 Million based on 36.99 Million shares outstanding and a price at last close of $2.09 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2017-05-15, Barberich picked up 30,000 at a purchase price of $2.45. This brings their total holding to 69,462 as of the date of the filing.
On the sell side, the most recent transaction saw Kauffman unload 2,070 shares at a sale price of $6.46. This brings their total holding to 0.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Verastem Inc. (NASDAQ:VSTM) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.